Company intelligence / Profile preview

ToeFX

Hamilton, Ontario, Canadatoefx.com ↗

Ownership: Private
Development stage: Other

Overview

Multi-site clinical studies at three Canadian centers showed that after six months of treatment with the patented light therapy system, approximately 76% of patients achieved good-to-excellent clearance of their fungal nail infection. Patient satisfaction was high—91% were “satisfied” or “highly satisfied,” and no adverse events were reported. Over 25,000 treatments have been administered globally.

Therapeutic areas: Infectious Diseases
Modalities: Device (light therapy)Non-pharmacological therapy (photodisinfection)Diagnostic aid
Industry: Therapeutic Medical Devices

Partnerships

R&D partnership with McMaster University

Beyond the preview

Go deeper on ToeFX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ToeFX.

Explore the full profile